NCT00158782 2017-11-17Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer PatientsGlaxoSmithKlinePhase 1 Completed75 enrolled
NCT00516672 2017-11-13Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid TumorsGlaxoSmithKlinePhase 1 Completed30 enrolled